Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
about
Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell functionSystematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitusPhysiologic characterization of type 2 diabetes-related lociGenetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageingNovel phenotypes of prediabetes?Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitusZinc transporter 8 (ZnT8) and β cell functionZinc and zinc transporter regulation in pancreatic islets and the potential role of zinc in islet transplantationDown-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretionEvaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell functionGene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathwaysGenome-wide association studies in type 2 diabetesGenetic mapping in human diseaseNovel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes.Variance of the SGK1 gene is associated with insulin secretion in different European populations: results from the TUEF, EUGENE2, and METSIM studies.Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association dataNovel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study.Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort.Zinc transporters and their role in the pancreatic β-cell.Association of COL4A3 (rs55703767), MMP-9 (rs17576)and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetesThe longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI.Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studiesGenetics of type 2 diabetes in European populations.Genetic variants of IDE-KIF11-HHEX at 10q23.33 associated with type 2 diabetes risk: a fine-mapping study in Chinese population.Polymorphism rs11085226 in the gene encoding polypyrimidine tract-binding protein 1 negatively affects glucose-stimulated insulin secretion.Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis.Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study.Association between SLC30A8 rs13266634 Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis.Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis studyZnt7-null mice are more susceptible to diet-induced glucose intolerance and insulin resistance.Interactions between genetic background, insulin resistance and β-cell function.SLC30A8 (ZnT8) Polymorphism is Associated with Young Age at Type 1 Diabetes Onset.Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention programDiabetes genes identified by genome-wide association studies are regulated in mice by nutritional factors in metabolically relevant tissues and by glucose concentrations in islets.A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.Cholesterol in islet dysfunction and type 2 diabetesGenetic Variation and Insulin Resistance in Middle-Aged Chinese MenGenetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism.Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion.
P2860
Q21092163-37DE8EBE-8C0D-4C81-8C3E-F336B4635B14Q24289497-9010D662-0CBB-4A86-B8C7-3A1C1385CE5FQ24630735-50D32606-4669-437D-9912-40A194C80208Q26746405-30EA5E1E-CAEA-4244-B38A-AD99751871C1Q26747128-39B835E0-298D-4DB2-AB77-A5A356CA4DB0Q26749481-A9370BC4-E57C-4250-964F-8AC935407D52Q26829276-EE310FF1-2B91-473B-AE2B-003D529DDA79Q28390590-93957B60-DE01-4CC9-840F-4942349BF509Q28564600-B0CB189A-CF8E-4095-8E33-D48DE19D0368Q28744489-794CEA95-873C-4FE4-B455-3D4C9BD0319CQ28752071-EAC89018-C046-4EE7-8A3E-EE8AE2C445B5Q28752564-5BCEE86D-2104-4EEC-A058-354749A33469Q29614943-CDF2D4C5-85AB-4B6B-97F6-BF728D28B973Q33361629-EC7483CB-9A30-4FDB-9ED9-F61562454AABQ33382733-D162BD72-BCEF-4896-88E7-BE2335C3D46DQ33389729-523A2358-E270-4956-BAF2-7717071F5A1FQ33394569-BFFAB7FC-2E26-41C8-A4FB-F46C3EB019D8Q33531795-8B2A0043-54D3-4F80-916D-D531CB0C56CBQ33585706-F2E2D532-F00F-4394-9D4C-2718E455FD08Q33598712-DA248DE5-21F9-4FBA-B82B-C59319C3E1C7Q33712531-6EA1E6E0-D7A3-4B84-8663-2D6D5A10000FQ33754521-96FD0B1B-0BEE-4B4F-989C-E6F373EAAEC8Q34032738-C9B72800-1C8B-4178-850A-BF37FDE4F5F2Q34233822-7B7D9D58-151D-475F-970E-E06ABE427505Q34450307-E7B72205-2276-4B42-A8CC-627E0F7BFDBBQ34631381-C1A5C175-FCB2-432D-96F0-570B77709804Q35083749-D70D2B4D-DF22-4272-B8E4-98ED6649F621Q35715829-4945A18A-E368-4D14-83BE-5FFF8CFDEE1EQ36249785-229CC2B9-E932-4B58-AC55-B01BD2A5FCC6Q36286218-7A8F79BA-4F57-46DD-9448-702C7DCCA709Q36790858-5EC735FF-56D6-40BB-B8FD-EDE34F392EB3Q36839340-7845D808-3131-47B3-8038-55283061BDEAQ36842653-4B38A951-B184-4F7E-99FC-129880B05F0AQ36877444-9DC46E8C-EF4E-4428-B229-16F2DBC4A2D0Q36906356-0B5E2A62-4FE5-44B9-A7A5-99999349E4D7Q36906418-E2021D46-2A46-422B-861E-A0C2AA20E657Q37075881-FA231310-31FA-48B1-A906-B927FD8A0171Q37104340-540BDD85-5A32-420B-AE43-DEA29C026F17Q37193726-7F245665-985C-465A-950C-1176580E4A90Q37236329-87465B3E-6CBC-4C3F-A09C-8CCC0E744458
P2860
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@ast
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@en
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@nl
type
label
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@ast
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@en
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@nl
prefLabel
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@ast
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@en
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@nl
P2093
P2860
P50
P1433
P1476
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
@en
P2093
Andreas Fritsche
Claus Thamer
Fausto Machicao
Kerstin Kirchhoff
Konstantinos Kantartzis
Otto Tschritter
Silke A Schäfer
P2860
P356
10.1371/JOURNAL.PONE.0000832
P407
P577
2007-09-05T00:00:00Z